MIP Diagnostics

A New World of Diagnostics with nanoMIPs

MIP is focussed on developing synthetic antibodies made from molecularly imprinted polymers (MIPs) that can be used in applications where antibodies traditionally struggle. MIPs have successfully been created and deployed against all major target classes including peptides, proteins and other macromolecular structures, as well as smaller chemical entities such as drugs, their metabolites and commonly used biochemical species such as enzyme cofactors.

Key facts

Sector - Healthcare

When Downing first invested - 2020

Website - www.mip-dx.com